584 related articles for article (PubMed ID: 23770081)
1. Rho-associated kinase inhibitors: a novel glaucoma therapy.
Inoue T; Tanihara H
Prog Retin Eye Res; 2013 Nov; 37():1-12. PubMed ID: 23770081
[TBL] [Abstract][Full Text] [Related]
2. Modulation of aqueous humor outflow facility by the Rho kinase-specific inhibitor Y-27632.
Rao PV; Deng PF; Kumar J; Epstein DL
Invest Ophthalmol Vis Sci; 2001 Apr; 42(5):1029-37. PubMed ID: 11274082
[TBL] [Abstract][Full Text] [Related]
3. Rho/Rho-associated kinase pathway in glaucoma (Review).
Wang J; Liu X; Zhong Y
Int J Oncol; 2013 Nov; 43(5):1357-67. PubMed ID: 24042317
[TBL] [Abstract][Full Text] [Related]
4. Impact of the clinical use of ROCK inhibitor on the pathogenesis and treatment of glaucoma.
Honjo M; Tanihara H
Jpn J Ophthalmol; 2018 Mar; 62(2):109-126. PubMed ID: 29445943
[TBL] [Abstract][Full Text] [Related]
5. [The possibility of selective Rho-associated kinase (ROCK) inhibitors as a medical treatment for glaucoma].
Honjo M
Nippon Ganka Gakkai Zasshi; 2009 Nov; 113(11):1071-81. PubMed ID: 19994585
[TBL] [Abstract][Full Text] [Related]
6. Effects of rho-associated protein kinase inhibitor Y-27632 on intraocular pressure and outflow facility.
Honjo M; Tanihara H; Inatani M; Kido N; Sawamura T; Yue BY; Narumiya S; Honda Y
Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):137-44. PubMed ID: 11133858
[TBL] [Abstract][Full Text] [Related]
7. The aqueous humor outflow pathways in glaucoma: A unifying concept of disease mechanisms and causative treatment.
Braunger BM; Fuchshofer R; Tamm ER
Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):173-81. PubMed ID: 25957840
[TBL] [Abstract][Full Text] [Related]
8. Rho kinase inhibitors for glaucoma treatment - Review.
Germano RA; Finzi S; Challa P; Susanna Junior R
Arq Bras Oftalmol; 2015; 78(6):388-91. PubMed ID: 26677046
[TBL] [Abstract][Full Text] [Related]
9. Rho kinase inhibitors-a review on the physiology and clinical use in Ophthalmology.
Moura-Coelho N; Tavares Ferreira J; Bruxelas CP; Dutra-Medeiros M; Cunha JP; Pinto Proença R
Graefes Arch Clin Exp Ophthalmol; 2019 Jun; 257(6):1101-1117. PubMed ID: 30843105
[TBL] [Abstract][Full Text] [Related]
10. Ripasudil hydrochloride hydrate: targeting Rho kinase in the treatment of glaucoma.
Inoue T; Tanihara H
Expert Opin Pharmacother; 2017 Oct; 18(15):1669-1673. PubMed ID: 28893104
[TBL] [Abstract][Full Text] [Related]
11. Expression of dominant negative Rho-binding domain of Rho-kinase in organ cultured human eye anterior segments increases aqueous humor outflow.
Rao PV; Deng P; Maddala R; Epstein DL; Li CY; Shimokawa H
Mol Vis; 2005 Apr; 11():288-97. PubMed ID: 15889013
[TBL] [Abstract][Full Text] [Related]
12. Morphological and hydrodynamic correlates in monkey eyes with laser induced glaucoma.
Zhang Y; Toris CB; Liu Y; Ye W; Gong H
Exp Eye Res; 2009 Nov; 89(5):748-56. PubMed ID: 19591828
[TBL] [Abstract][Full Text] [Related]
13. Rho GTPase/Rho kinase inhibition as a novel target for the treatment of glaucoma.
Rao VP; Epstein DL
BioDrugs; 2007; 21(3):167-77. PubMed ID: 17516712
[TBL] [Abstract][Full Text] [Related]
14. Role of the Rho GTPase/Rho kinase signaling pathway in pathogenesis and treatment of glaucoma: Bench to bedside research.
Rao PV; Pattabiraman PP; Kopczynski C
Exp Eye Res; 2017 May; 158():23-32. PubMed ID: 27593914
[TBL] [Abstract][Full Text] [Related]
15. The role of protein kinase C in modulation of aqueous humor outflow facility.
Khurana RN; Deng PF; Epstein DL; Vasantha Rao P
Exp Eye Res; 2003 Jan; 76(1):39-47. PubMed ID: 12589774
[TBL] [Abstract][Full Text] [Related]
16. Targeting Schlemm's Canal in the Medical Therapy of Glaucoma: Current and Future Considerations.
Andrés-Guerrero V; García-Feijoo J; Konstas AG
Adv Ther; 2017 May; 34(5):1049-1069. PubMed ID: 28349508
[TBL] [Abstract][Full Text] [Related]
17. The trabecular meshwork outflow pathways: structural and functional aspects.
Tamm ER
Exp Eye Res; 2009 Apr; 88(4):648-55. PubMed ID: 19239914
[TBL] [Abstract][Full Text] [Related]
18. Intraocular Pressure and the Mechanisms Involved in Resistance of the Aqueous Humor Flow in the Trabecular Meshwork Outflow Pathways.
Tamm ER; Braunger BM; Fuchshofer R
Prog Mol Biol Transl Sci; 2015; 134():301-14. PubMed ID: 26310162
[TBL] [Abstract][Full Text] [Related]
19. AMA0076, a novel, locally acting Rho kinase inhibitor, potently lowers intraocular pressure in New Zealand white rabbits with minimal hyperemia.
Van de Velde S; Van Bergen T; Sijnave D; Hollanders K; Castermans K; Defert O; Leysen D; Vandewalle E; Moons L; Stalmans I
Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):1006-16. PubMed ID: 24474276
[TBL] [Abstract][Full Text] [Related]
20. Effects of K-115, a rho-kinase inhibitor, on aqueous humor dynamics in rabbits.
Isobe T; Mizuno K; Kaneko Y; Ohta M; Koide T; Tanabe S
Curr Eye Res; 2014 Aug; 39(8):813-22. PubMed ID: 24502505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
